GRCE
Grace TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
GRCE vs peer average
85/100
GRCE vs. peer average (B vs. D)
Grade spread
A 1 · B 1 · D 2 · F 7
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
TLPH is the first available peer comparator.
Talphera remains the closest operating comp from the prior baseline because both are small-cap hospital-focused drug stories with meaningful regulatory and commercialization event risk, even though the indications differ.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
GRCE
Grace Therapeutics
TLPH
Talphera
Grade
B
D
Momentum
70
51
Value
41
41
Sentiment
67
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs TLPH
GRCE / TLPH
Grade Position
Above peers
GRCE vs. peer average (B vs. D)
85/100
Momentum
70
GRCEValue
41
GRCESentiment
67
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs GRCE
TLPH is the first peer returned for this comparison set.